Microbiological evaluation of commercial probiotic products available in the USA in 2009

Journal of Chemotherapy

Volumn 22, Issue 6, 2010, Pages 373-377

  Drago, L ^a,b   Rodighiero, V ^a   Celeste, T ^b   Rovetto, L ^a   de Vecchi, E ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

Author keywords

Bacteria identification; Label correctness; Probiotics; Quality assessment

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; BACILLUS COAGULANS; BACTERIAL VIABILITY; BACTERIUM CONTAMINATION; BACTERIUM IDENTIFICATION; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM INFANTIS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS HELVETICUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS SALIVARIUS; MICROBIOLOGICAL EXAMINATION; NONHUMAN; QUALITY CONTROL; STREPTOCOCCUS THERMOPHILUS; UNITED STATES; BIFIDOBACTERIUM; FOOD CONTROL; FOOD PACKAGING; HUMAN; ISOLATION AND PURIFICATION; LACTOBACILLUS; MARKETING; MICROBIAL VIABILITY; PACKAGING; STANDARD;

BIFIDOBACTERIUM; FOOD LABELING; FOOD MICROBIOLOGY; HUMANS; LACTOBACILLUS; MARKETING; MICROBIAL VIABILITY; PROBIOTICS; PRODUCT PACKAGING; UNITED STATES;

EID: 79958294988     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/joc.2010.22.6.373     Document Type: Article

References (25)

1. FAO/WHO. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. 2001. Available at: http://www.who.int/foodsafety/publicarions/fs_manage-ment/en/probiotics.pdf
2. Wassenaar TM, Klein G. Safety aspects and implications of regulation of probiotic bacteria in food and food supplements. J Food Prot 2008; 71 (8): 1734-1741.
3. Lu L, Walker WA. Pathologic and physiologic interactions of bacteria with the gastrointestinal epithelium. Am J Clin Nutr 2001; 73 (6): 1124S-1130S.
4. Vanderhoof JA, Young R. Probiotics in the United States. Clin Infect Dis 2008; 46 Suppl 2: S67-72.
5. Temmerman R, Pot B, Huys G, Swings J. Identification and antibiotic susceptibility of bacterial isolates from probiotic products. Int J Food Microbiol 2003; 81 (1): 1-10.
6. Elliott E, Teversham K. An evaluation of nine probiotics available in South Africa, August 2003. S Afr Med J 2004; 94 (2): 121-124.
7. Fasoli S, Marzotto M, Rizzotti L, Rossi F, Dellaglio F, Torriani S. Bacterial composition of commercial probiotic products as evaluated by PCR-DGGE analysis. Int J Food Microbiol 2003; 82 (1): 59-70.
8. Aureli P, Hore A, Scalfaro C, Casale M, Franciosa G. National survey outcomes on commercial probiotic food supplements in Italy. Int J Food Microbiol 2010; 137 (2-3): 265-273.
9. Sharp MD, McMahon DJ, Broadbent JR. Comparative evaluation of yogurt and low-fat cheddar cheese as delivery media for probiotic Lactobacillus casei. J Food Sci 2008; 73 (7): 375-377.
10. Drago L, De Vecchi E, Nicola L, Colombo A, Gismondo MR. Micro- biological evaluation of commercial probiotic products available in Italy. J Chemother 2004; 16 (5): 463-467.
11. Wannaprasat W, Koowatanankul C, Ekkapobyotin C, Chuanchuen R. Quality analysis of commercial probiotic products for food animals. South- east Asian J Trap Med Public Health 2009; 40 (5) 1103-1112.
12. Drisko J, Bischoff B, Giles C, Adelson M, Rao RV, McCallum R. Eval-uation of five probiotic products for label claims by DNA extraction and poly- merase chain reaction analysis. Dig Dis Sci 2005; 50 (6): 1113-1117.
13. Huys G, Vancanneyt M, D'Haene K, Vankerckhoven V, Goossens H, Swings J. Accuracy of commercial bacterial cultures intended for probiotic or nutritional use. Res Microbiol 2006; 157 (9): 803-810.
14. Milazzo I, Speciale A, Musumeci R, Fazio D, Blandino G. Identifica- tion and antibiotic susceptibility of bacterial isolates from probiotic products available in Italy. New Microbiol 2006; 29 (4): 281-291.
15. US Food and Drug Administration. Dietary Supplement and Health Education Act. 1994. Available at: http://www.fda.gov/RegulatoryInformation/Legisla-tion/FederalFoodDrugandCosmeticActFDCAct/SignificantAmend-mentstotheFDCAct/ucml48003.htm
16. US Food and Drug Administration. Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements. 2007. Available at: http://edocket.access.gpo.gov/2007/07-3039.htm
17. de Vrese M, Schrezenmeir J. Probiotics, prebiotics and synbiotics. Adv Biochem Eng Biotechnol 2008; 111: 1-66.
18. Wolvers D, Antoine JM, Myllyluoma E, Schrezenmeir J, Szajewska H, Rijkers GT. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics. J Nutr 2010; 140 (3): 698S-712S.
19. Stamatova I, Meurman JH. Probiotics: health benefits in the mouth. Am J Dent 2009; 22 (6): 329-338.
20. Lomax AR, Calder PC. Probiotics, immune function, infection and in- flammation: a review of the evidence from studies conducted in humans. Curr Pharm Des 2009; 15 (13): 1428-1518.
21. Senok AC, Verstraelen H, Temmerman M, Botta GA. Probiotics for the treatment of bacterial vaginosis. Cochrane Database Syst Rev, 2009; CD006289.
22. Weese JS. Evaluation of deficiencies in labeling of commercial probi- otics. Can Vet J 2003; 44 (12): 982-983.
23. Lund B, Edlund C. Probiotic Enterococcus faecium strain is a possi- ble recipient of the vanA gene cluster. Clin Infect Dis 2001; 32 (9): 1384-1385.
24. Paoletti C, Foglia G, Princivalli MS, Magi G, Guaglianone E, Donelli G, et al. Co-transfer of vanA and aggregation substance genes from Ente- rococcus faecalis isolates in intra- and interspecies matings. J Antimicrob Chemother 2007; 59 (5): 1005-1009.
25. Morgan CA, Herman N, White PA, Vesey G. Preservation of micro- organisms by drying; a review. J Microbiol Methods 2006; 66 (2): 183-193.